Sequella Employee Directory

Sequella corporate office is located in 9610 Medical Center Dr Ste 200, Rockville, Maryland, 20850, United States and has 11-50 employees.

Sequella Global Presence

globalPresence illustration
North America1-10

Sequella CEO

Carol Nacy, Co-Founder & Chief Executive Officer & Chairman, Directors at Sequella
United States flag for contact location.
Carol NacyCo-Founder & Chief Executive Officer & Chairman, Directors
PhonePhoneEmailEmail
See Profile

Key Employees of Sequella

  • DM
    United States flag for contact location.
    David Mc Neele...

    Global Senior VP, Medical Programs

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

Index of contact profiles from Sequella

Hundreds of professionals searching for Sequella have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

Former Employees at Sequella

Explore people who held key positions, contributed to Sequella's success, and advanced their careers.

  1. Program, Cor & Chair o... at National Institutes of...

    Worked as Vice President, Therapeutics

    at Sequella (2007-2016)

    email Marina Protopopova Email direct Marina Protopopova Direct

Explore More

People from Similar Companies in the Manufacturing Industry Located in Maryland, United States

Frequently Asked Questions Regarding Sequella Employees

How many employees does Sequella have?
Sequella has 11-50 employees
Who is the CEO of Sequella?
Sequella’s CEO is Carol Nacy
Who are Sequella key employees?
Some of Sequella key employees are David Mc Neeley
Where is Sequella located?
Sequella’s headquarters are located at 9610 Medical Center Dr Ste 200, Rockville, Maryland, 20850, United States
How do I contact Sequella?
Sequella Contact Info: Phone number: (301) 762-7776 Website: www.sequella.com
What does Sequella do?

Sequella is a clinical-stage pharmaceutical company focused on developing innovative antibiotics to combat drug-resistant bacterial, fungal, and parasitic infections. Their product pipeline targets significant global health issues, particularly tuberculosis (TB) and its multidrug-resistant forms, which impact over 3 billion people worldwide. With d... rug candidates like SQ109 and sutezolid having completed phase 2 clinical trials, Sequella aims to address the urgent need for effective treatments in this area. The company also explores therapies for other serious infections, including those caused by Clostridium difficile and various parasitic diseases.Read More

Is Sequella a public company?
Sequella is private company therefore does not currently have an official ticker symbol
See more information about Sequella Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.